Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S217000, C514S375000
Reexamination Certificate
active
07947719
ABSTRACT:
The present invention relates to a novel group of compounds having antibiotic, antifungal and/or cytostatic properties, which are obtainable from myxobacteria, especially of the genusSorangium, preferablySorangium cellulosum. One representative of this group of compounds is currently named Disorazole Z and Disorazole Z-epoxide, respectively, with specific substituents and specific unsaturated bonds to its cyclic core structure:
REFERENCES:
Jin, Zhong, 2006; Natural Product Reports; vol. 23, 464-496.
Wipf et. al., 2006; Chemical and Biological Drug Design; vol. 67; pp. 66-73.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Jansen, et. al.; Liebigs Annalen der Chemie (1994), (8), 759-73.
R. Jansen et al: “Antibiotics from gliding bacteria. LIX. Disorazoles, highly cytoxic metabolites from the sorangicin-producing bacterium Sorangium cellulosum, strain So ce12” Liebigs Annalen Der Chemie, Verlag Chemie GMBH. Weinheim, DE, 1994, pp. 759-773, XP002265587, ISSN: 0170-2041.
R. Jansen, et al: “Chivosazoles A-F: Novel Antifungal and Cytotoxic Macrolides fro Sorangium cellulosum (Myxobacteria)” Liebigs Ann./Recueil 1997 1725-1732.
Yeh, Tetrahedron report 698, Tetrahedrom 60 (2004) 11995-12042.
Wipf, Graham, “Total Synthesis of(-)-Disorazole Cl,” J. Am Chem. Soc. 2004, 126, 153456-7.
Hartung et al., “Toward the total synthesis for Disorazole A 1: Asymmetric synthesis of the masked northern half,” Synthesis 2003, No. 12, 1844-1850.
Haustedt et al., “Synthetic studies towards the disorazoles: Synthesis of a mask northern half of Disorazole D1 and a cyclopropane analog of the masked northern half of Disorazole A1 ,” Tetrahedrom 59 (2003) 6967-6977.
Hillier, Price, Meyers, “Studies on the total synthesis of Disorazole Cl. An advanced macrocycle intermediate,” J. Org. Chem. 2001 66,6037-6045, Table 1.
Scudiero, et al, “Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines,” Cancer Research: 48, 4827-4833, Sep. 1, 1988.
Schmidt, et al, “Differential Modulation of paclitaxel-Mediated Apoptosis by p21Waf1and p27Kip1,” Oncogene (2000) 19, 2423-2429.
Irschik Herbert
Jansen Rolf
Sasse Florenz
Greer Burns & Crain Ltd.
Hemholtz-Zentrum fur Infektionsforschung GmbH
Ward Paul V.
LandOfFree
Biologically active compounds obtainable from Sorangium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active compounds obtainable from Sorangium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active compounds obtainable from Sorangium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2636594